Two similarly controlled landmark trials provide conflicting results regarding the clinical guidelines for management of acute hypertension in individuals with intracerebral hemorrhage. However, focusing exclusively on blood pressure targets may obscure a critical finding.
Intracranial aneurysms are detected in 9% of patients with autosomal dominant polycystic kidney disease undergoing magnetic resonance angiography screening.
Investigators sought to determine the safety and efficacy of novel oral anticoagulants to treat patients with chronic kidney disease, particularly with regard to cardiovascular outcomes.
For patients with mild-to-moderate Alzheimer disease, treatment with nilvadipine lowers systolic blood pressure and increases cerebral blood flow (CBF) in the hippocampus.
Patients with hypertension with progression of periventricular white matter hyperintensities have an increased risk for incident mild cognitive impairment.
Systemic vascular health measured as a composite of recent cardiovascular and metabolic chronic conditions was associated with medial temporal lobe thinning, widespread cerebral hypoperfusion, and poor microstructural integrity.
